Prenatal exome sequencing for fetuses with structural abnormalities: The next step

Ultrasound in Obstetrics and Gynecology

Volumn 45, Issue 1, 2015, Pages 4-9

  Hillman, S C ^a,b   Willams, D ^b   Carss, K J ^c   Mcmullan, D J ^b   Hurles, M E ^b   Kilby, M D ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME ABERRATION; EXOME; FEMALE; GENETIC COUNSELING; HUMAN; NUCLEOTIDE SEQUENCE; PILOT STUDY; PREGNANCY; PRENATAL DIAGNOSIS; PROGNOSIS; TRENDS;

CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; EXOME; FEMALE; GENETIC COUNSELING; HUMANS; PILOT PROJECTS; PREGNANCY; PRENATAL DIAGNOSIS; PROGNOSIS;

EID: 84920878583     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14653     Document Type: Editorial

References (27)

1. Springett A. Congenital anomaly statistics. In Congenital Anomaly Statistics: England and Wales, Morris J (ed). British Isles Network of Congenital Anomaly Registers: London, 2010.
2. Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996; 7: 216-226.
3. Cereda A Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis 2012; 7: 81.
4. Hillman SC, McMullan DJ, Hall G, Togneri FS, James N, Maher EJ, Meller CH, Williams D, Wapner RJ, Maher ER, Kilby MD. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013; 41: 610-620.
5. Skinner MA, Safford SD, Reeves JG, Jackson ME, Freemerman AJ. Renal aplasia in humans is associated with RET mutations. Am J Hum Genet 2008; 82: 344-351.
6. Rousseau F, el Ghouzzi V, Delezoide AL, Legeai-Mallet L, Le Merrer M, Munnich A, Bonaventure J. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet 1996; 5: 509-512.
7. Carss KJ, Hillman SC, Parthiban V, McMullan DJ, Maher ER, Kilby MD, Hurles ME. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Human Mol Genet 2014; 23: 3269-3277.
8. Gergev G, Mate A, Zimmermann A, Rarosi F, Sztriha L. Spectrum of neurodevelopmental disabilities: A cohort study in Hungary. J Child Neurol 2014 (Epub ahead of print).
9. Shaffer LG, Bejjani BA. A cytogeneticist's perspective on genomic microarrays. Hum Reprod Update 2004; 10: 221-226.
10. Huber J, Peres VC, de Castro AL, Dos Santos TJ, da Fontoura Beltrão L, de Baumont AC, Cossio SL, Dalberto TP, Riegel M, Canedo AD, Schaan BD, Pellanda LC. Molecular screening for 22q11.2 deletion syndrome in patients with congenital heart disease. Pediatr Cardiol 2014 (Epub ahead of print).
11. Brackley KJ, Kilby MD, Morton J, Whittle MJ, Knight SJ, Flint J. A case of recurrent congenital fetal anomalies associated with a familial subtelomeric translocation. Prenat Diagn 1999; 19: 570-574.
12. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Eng J Med 2012; 367: 2175-2184.
13. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013; 122: 1374-1377.
14. Bernhardt BA, Soucier D, Hanson K, Savage MS, Jackson L, Wapner RJ. Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 2013; 15: 139-145.
15. Stenson PD, Ball EV, Howells K, Phillips AD, Mort M, Cooper DN. The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics. Hum Genomics 2009; 4: 69-72.
16. Wang Z, Liu X, Yang BZ, Gelernter J. The role and challenges of exome sequencing in studies of human diseases. Front Genet 2013; 4: 160.
17. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Eng J Med 2013; 369: 1502-1511.
18. Robinson PN, Mundlos S. The human phenotype ontology. Clin Genet 2010; 77: 525-534.
19. Talkowski ME, Ordulu Z, Pillalamarri V, Benson CB, Blumenthal I, Connolly S, Hanscom C, Hussain N, Pereira S, Picker J, Rosenfeld JA, Shaffer LG, Wilkins-Haug LE, Gusella JF, Morton CC. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Eng J Med 2012; 367: 2226-2232.
20. Filges I, Nosova E, Bruder E, Tercanli S, Townsend K, Gibson W, Rothlisberger B, Heinimann K, Hall JG, Gregory-Evans CY, Wasserman WW, Miny P, Friedman JM. Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype. Clin Genet 2014; 86: 220-228.
21. Potocki L, Abuelo DN, Oyer CE. Cardiac malformation in two infants with hypochondrogenesis. Am JMed Genet A 1995; 59: 295-299.
22. Zankl A, Zabel B, Hilbert K, Wildhardt G, Cuenot S, Xavier B, Ha-Vinh R, Bonafe L, Spranger J, Superti-Furga A. Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1. Am J Med Genet A 2004; 129a: 144-148.
23. Bisschoff IJ, Zeschnigk C, Horn D, Wellek B, Riess A, Wessels M, Willems P, Jensen P, Busche A, Bekkebraten J, Chopra M, Hove HD, Evers C, Heimdal K, Kaiser AS, Kunstmann E, Robinson KL, Linne M, Martin P, McGrath J, Pradel W, Prescott KE, Roesler B, Rudolf G, Siebers-Renelt U, Tyshchenko N, Wieczorek D, Wolff G, Dobyns WB, Morris-Rosendahl DJ. Novel mutations including deletions of the entire OFD1 gene in 30 families with type 1 orofaciodigital syndrome: a study of the extensive clinical variability. Hum Mutat 2013; 34: 237-247.
24. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013; 15: 565-574.
25. Middleton A, Parker M, Wright CF, Bragin E, Hurles ME. Empirical research on the ethics of genomic research. Am J Med Genet A 2013; 161a: 2099-2101.
26. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-689.
27. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nature Rev Genet 2011; 12: 745-755.